Literature DB >> 2304237

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

M J Alter1, S C Hadler, H S Margolis, W J Alexander, P Y Hu, F N Judson, A Mares, J K Miller, L A Moyer.   

Abstract

To determine trends in the incidence and epidemiology of acute hepatitis B in the United States we conducted intensive surveillance for viral hepatitis in four sentinel counties from October 1, 1981, to September 30, 1988. The overall incidence of hepatitis B remained relatively constant throughout the study period (average, 13.2 cases per 100,000 population), but disease transmission patterns changed significantly. The proportions of hepatitis B cases accounted for by homosexual activity and health care employment decreased 62% and 75%, respectively; the proportions of cases accounted for by parenteral drug use and heterosexual exposure increased 80% and 38%, respectively. The percentage of patients for whom no risk factor was identified (30% to 40%) did not change over time. These patients tended to belong to minority populations, and their socioeconomic level was low. The decline in the number of hepatitis B cases among homosexual men probably results from the modification of high-risk sexual behavior; the decline among health care workers is due mostly to hepatitis B immunization. The current strategy for prevention of hepatitis B, which targets high-risk groups for immunization, has failed to have a significant impact on the incidence of disease.

Entities:  

Mesh:

Year:  1990        PMID: 2304237

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  82 in total

1.  Challenges to the economic evaluation of new biotechnological interventions in healthcare.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

2.  Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men.

Authors:  M S Friedman; P A Blake; J E Koehler; L C Hutwagner; K E Toomey
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

3.  Preventing hepatitis B.

Authors:  N Cimolai
Journal:  CMAJ       Date:  1992-07-01       Impact factor: 8.262

4.  Determinants of hepatitis B virus surface antigen positivity in adults attending sexually transmitted disease clinics in Italy.

Authors:  F Parazzini; L C D'oro; C Bianchi; C Mezzanotte; L Naldi; G L Imberti; B Pansera; T Cainelli; A Carlino; S Graefemberghi
Journal:  Genitourin Med       Date:  1992-10

5.  Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.

Authors:  L Salleras; M Bruguera; J Vidal; J L Taberner; P Plans; J M Bayas; T Pumarola; M T Jimenez de Anta; J Rodés
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

6.  Universal hepatitis B vaccination: the economics of prevention.

Authors:  M D Krahn; A S Detsky
Journal:  CMAJ       Date:  1992-01-01       Impact factor: 8.262

7.  Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-01-01       Impact factor: 8.262

8.  Universal vaccination against hepatitis B.

Authors: 
Journal:  CMAJ       Date:  1992-01-01       Impact factor: 8.262

9.  Moving towards a universal hepatitis B vaccine program for Canadian children.

Authors:  N Macdonald
Journal:  Can J Infect Dis       Date:  1995-05

10.  Targeted versus universal vaccination against hepatitis B: A paradigm shift.

Authors:  J M Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.